NCT03157128 2026-04-16LIBRETTO-001Eli Lilly and CompanyPhase 1/2 Active not recruiting857 enrolled 24 charts 6 FDA
NCT03093116 2026-04-03TRIDENT-1Turning Point Therapeutics, Inc.Phase 1/2 Recruiting500 enrolled 4 FDA
NCT05660954 2026-04-02CABOTHYROIDGrupo Espanol de Tumores NeuroendocrinosPhase 2 Active not recruiting41 enrolled
NCT04615988 2026-03-27Correlation Vitamin D Level to Endocrine Autoimmune Toxicity Due to Immune Checkpoint InhibitorsIcahn School of Medicine at Mount SinaiRecruiting17 enrolled